Use of a subcutaneous ICD in a patient with short QT syndrome.
about
Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study.In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.Therapeutic effects of a taurine-magnesium coordination compound on experimental models of type 2 short QT syndrome.
P2860
Use of a subcutaneous ICD in a patient with short QT syndrome.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Use of a subcutaneous ICD in a patient with short QT syndrome.
@en
Use of a subcutaneous ICD in a patient with short QT syndrome.
@nl
type
label
Use of a subcutaneous ICD in a patient with short QT syndrome.
@en
Use of a subcutaneous ICD in a patient with short QT syndrome.
@nl
prefLabel
Use of a subcutaneous ICD in a patient with short QT syndrome.
@en
Use of a subcutaneous ICD in a patient with short QT syndrome.
@nl
P2093
P2860
P356
P1476
Use of a subcutaneous ICD in a patient with short QT syndrome
@en
P2093
Alexandre Duparc
Anne Rollin
Christelle Cardin
Pierre Mondoly
P2860
P356
10.1002/CCR3.432
P577
2015-11-11T00:00:00Z